Has Simon Oh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $112,381 in general payments to Simon Oh, MD across 1,369 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Simon Oh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Simon Oh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Simon Oh, MD

Neurology · Aurora, CONPI 1649236191

Payments from drug & device makers

$112,381in general payments, 2019–2025

Across 1,369 payments — averaging $82.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$38K
AstraZeneca$16K
Teva Pharmaceuticals USA, Inc.$12K
Pfizer$7K
Argenx US, Inc.$7K
Grifols USA, LLC$6K
plus $26K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	310	$38,354
AstraZeneca	75	$15,801
Teva Pharmaceuticals USA, Inc.	74	$11,560
Pfizer	44	$7,245
Argenx US, Inc.	56	$7,027
Grifols USA, LLC	18	$6,353
Livanova USA, Inc.	35	$4,656
SK Life Science, Inc.	30	$2,367
UCB, Inc.	70	$2,140
Amgen	53	$1,396
Lundbeck LLC	32	$1,213
Bristol Myers Squibb	50	$1,206
Abbott	17	$1,089
Eisai Inc.	33	$885
MDD US Operations, LLC	23	$773
Sanofi	21	$688
Zyla Life Sciences, Inc.	52	$598
Alnylam Pharmaceuticals Inc.	26	$595
Upsher-smith Laboratories LLC	32	$592
Catalyst Pharmaceuticals, Inc.	25	$580
Acorda Therapeutics, Inc	21	$496
Novartis	22	$461
Supernus Pharmaceuticals, Inc.	28	$445
Biogen	18	$365
Acadia Pharmaceuticals Inc	13	$358
Sunovion Pharmaceuticals Inc.	19	$328
CSL Behring	11	$314
Inspire Medical Systems, Inc.	3	$304
Axsome Therapeutics, Inc.	7	$281
EMD Serono, Inc.	10	$278
Impel Pharmaceuticals Inc.	13	$268
E.r. Squibb & Sons, L.L.C.	2	$250
Medtronic(2 entities)	11	$238
Jazz Pharmaceuticals Inc.	4	$212
Genentech USA, Inc.	9	$204
Biohaven Pharmaceutical Holding Company Ltd.	9	$190
Almatica Pharma LLC	8	$189
Adamas Pharmaceuticals, Inc.	7	$156
Neurocrine Biosciences, Inc.	3	$153
Merz Pharmaceuticals, LLC	6	$150
Grifols Shared Services North America, Inc.	1	$127
Neurelis, Inc.	4	$112
Greenwich Biosciences, Inc.	3	$110
Takeda Pharmaceuticals U.S.A., Inc.	4	$109
Biohaven Pharmaceuticals, Inc.	4	$106
Lilly USA, LLC	5	$95
Sumitomo Pharma America, Inc.	7	$93
Nevro Corp.	3	$90
TG Therapeutics, Inc.	3	$82
Tonix Medicines, Inc.	3	$67
Collegium Pharmaceutical, Inc.	3	$67
Vertical Pharmaceuticals, LLC	3	$59
Promius Pharma LLC	3	$59
Mallinckrodt Enterprises LLC	4	$58
Bausch Health US, LLC	3	$57
Merz North America, Inc.	2	$54
Insightec,inc	1	$51
Banner Life Sciences, LLC	2	$46
Tanabe Pharma America, Inc.	2	$35
Azurity Pharmaceuticals, Inc.	2	$34

How this compares

$112,381 in reported general payments places this provider in the 80th percentile of 334 neurology providers in Colorado.

See all neurology providers in Colorado →

Medicare billing

Part B allowed, 2024

$676,481

Medicare patients

675

Services billed

55,962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Aurora

Enrique AlvarezAurora$14.3M
Timothy VollmerAurora$2M
Jeffrey BennettAurora$1.9M
Anna ShahAurora$1.4M
John CorboyAurora$1.3M
Amanda PiquetAurora$1.3M
Drew KernAurora$1.2M
Maureen LeeheyAurora$1.1M
Thomas RagoleAurora$841K
Denise DamekAurora$733K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →